UBS Maintains Buy on XP, Raises Price Target to $37

UBS analyst Thiago Batista has maintained a Buy rating on XP (NASDAQ: XP) and increased the price target from $25 to $37. This adjustment reflects a positive outlook for the company's performance in the market.